Vitamin C — what the clinical evidence shows, and what formulation requires.

Vitamin C is among the most clinically documented actives in skincare. It is also among the most commonly misformulated. Understanding what the evidence supports — and what it requires in formulation terms — separates useful products from expensive ones.

What vitamin C does

The evidence for topical vitamin C (L-ascorbic acid) is established across several mechanisms.

Antioxidant activity. L-ascorbic acid is a water-soluble antioxidant that neutralises free radicals in the epidermis — reactive oxygen species generated by UV exposure, pollution, and metabolic activity. This limits the oxidative damage that contributes to both accelerated ageing and skin cancer risk. Vitamin C applied before UV exposure has been shown to reduce UV-induced erythema and cell damage, independent of (and in addition to) SPF protection.

Melanin synthesis inhibition. Vitamin C inhibits tyrosinase, the enzyme required for melanin production. This is the mechanism behind its brightening effect — reduced production of the pigment responsible for post-inflammatory hyperpigmentation (PIH), melasma, and sun spots. The effect is dose-dependent and requires consistent application over weeks to be clinically visible.

Collagen synthesis support. L-ascorbic acid is a required cofactor for the enzymes that hydroxylate proline and lysine — two amino acids essential to collagen structure. Topical application at effective concentrations increases dermal collagen synthesis markers in controlled studies. The practical result is improved skin firmness and reduced appearance of fine lines over a period of months.

These three mechanisms are supported by peer-reviewed clinical evidence. The brightening, antioxidant, and collagen-supportive effects are real. They require the right form of vitamin C, at the right concentration, in the right formulation conditions.

The stability problem

L-ascorbic acid is chemically unstable. It oxidises on contact with air, light, and water — degrading progressively from active ascorbic acid to dehydroascorbic acid (partially active) and then to diketogulonic acid (inactive). This oxidation is visible: a product that has turned yellow-orange-brown has undergone significant oxidative degradation and is unlikely to provide meaningful benefit.

This instability is the primary formulation challenge with vitamin C and the reason that many products fail to deliver the effects the evidence supports.

What effective formulation requires

Concentration. The clinical literature on L-ascorbic acid efficacy generally uses concentrations of 10–20%. Below 10%, the penetration and activity at the dermal level is likely insufficient for meaningful collagen synthesis effects. Above 20%, irritation increases without proportional efficacy gains. The sweet spot for most skin is 10–15%.

pH. L-ascorbic acid requires an acidic environment — pH 3.5 or below — to remain in its active protonated form and to penetrate the stratum corneum. At higher pH, it exists in an ionised form that does not penetrate well. Products that buffer vitamin C to a higher pH for tolerability significantly reduce its efficacy.

Packaging. An airtight, light-protected container is not a marketing choice — it is a formulation requirement. Products in open-neck jars or clear glass bottles expose each application to the precise conditions (air and light) that degrade vitamin C. Opaque airless pumps or dark glass with minimal headspace are the appropriate packaging for an L-ascorbic acid product.

Antioxidant synergy. Combining L-ascorbic acid with vitamin E (tocopherol) and ferulic acid is the most evidence-supported combination for increased stability and efficacy. The three together demonstrate synergistic antioxidant activity significantly exceeding any individual component. This combination is the basis of several of the most clinically studied vitamin C formulations.

The derivative question

Because of L-ascorbic acid's instability challenges, many products use vitamin C derivatives — ascorbyl glucoside, sodium ascorbyl phosphate, ascorbyl palmitate, and others. These are more stable but require conversion to L-ascorbic acid in the skin to be active.

The evidence for derivatives is thinner. Sodium ascorbyl phosphate has some decent data, particularly for acne-related concerns. Ascorbyl glucoside converts slowly and incompletely. Ascorbyl palmitate is oil-soluble but has poor skin conversion rates and may generate pro-oxidant activity.

If the mechanism of interest is antioxidant activity and collagen synthesis at the dermal level, L-ascorbic acid at 10–15%, correctly formulated and packaged, has the strongest evidence base. Derivatives are a reasonable second choice for skin that cannot tolerate the acidity of L-ascorbic acid formulas, with the acknowledgement that efficacy may be reduced.

Tolerability and introduction

L-ascorbic acid at 10–15% and pH ≤3.5 stings on application. This is expected and is not an indicator of barrier damage — it is the acidic pH making contact with sensory nerve endings. The stinging is transient (seconds) and reduces with regular use as the skin acclimates to the acidic pH.

For skin new to vitamin C or reactive to high-percentage products, introducing at 5–10% for the first few weeks before increasing concentration is a reasonable approach. Apply to clean, dry skin in the morning. Layering an active vitamin C product on recently applied retinoid or AHA is unnecessary and increases irritation risk.

Vitamin C and niacinamide together: the claim that the combination produces niacin flushing and should be avoided is not supported by modern formulation evidence. The reaction that produces niacin — the conversion of both compounds under heat — requires temperatures far above skin temperature. At room temperature and typical topical concentrations, vitamin C and niacinamide can be used in the same routine without this concern.

SPF is the non-negotiable partner

Vitamin C's antioxidant and brightening benefits are significantly undermined by UV exposure without protection. Hyperpigmentation that vitamin C is working to reduce is actively reinforced by unprotected sun exposure. Daily SPF 30+ is not a recommendation alongside vitamin C use — it is the condition under which the investment in vitamin C makes sense.

A useful morning routine structure

Apply vitamin C serum immediately after cleansing on clean, dry skin. Allow 30–60 seconds before layering moisturiser on top. Apply SPF last. This sequence preserves the activity of the vitamin C at the low-pH layer, applies moisturiser on top of the active, and SPF as the final barrier before UV exposure.

The Lux & Glo position

The foundational three-step ritual is built on niacinamide as the primary active — evidence-based for barrier support, hyperpigmentation reduction, and sebum regulation, with a tolerability profile that suits a wide range of skin types. Vitamin C is a logical addition for skin that has an established barrier and is looking for amplified brightening and antioxidant coverage.

The combination of niacinamide (barrier support, melanin dispersal, inflammation reduction) and vitamin C (tyrosinase inhibition, antioxidant activity, collagen synthesis) addresses hyperpigmentation from two complementary angles — one working on the production side, one on the dispersal and environmental protection side. Applied in sequence — vitamin C in the morning, niacinamide as part of the foundational serum — they reinforce rather than compete.

The evidence for both is strong. The condition is consistent, informed use over the months that clinical change requires.